Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
Dec 28, 2009 roberts william Officer Option Execute 12,500 8.50
Feb 2, 2010 kolinski stuart Officer Option Execute 12,314 8.50
Jul 27, 2011 goldberg murray a Officer Automatic Sell 12,258 53.18
Nov 2, 2009 brown michael s Director Disposition (Non Open Market) 12,000 n/a
Feb 2, 2010 roberts william Officer Option Execute 12,000 13.00
Dec 13, 2011 gilman alfred g Director Disposition (Non Open Market) 11,875 n/a
Feb 25, 2014 goldberg murray a Officer Automatic Sell 11,871 336.89 - 346.73
Jul 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,837 n/a
Jan 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,771 n/a
Aug 11, 2014 stahl neil Officer Sell 11,646 339.33 - 341.27
Oct 1, 2007 vagelos p roy Director Automatic Sell 11,560 n/a
Nov 13, 2012 goldberg murray a Officer Automatic Sell 11,557 144.36 - 148.05
Mar 21, 2011 goldstein joseph l Director Automatic Sell 11,505 40.00
Nov 27, 2012 roberts william Officer Disposition (Non Open Market) 11,500 n/a
Nov 30, 2012 roberts william Officer Sell 11,500 177.43 - 186.00
Nov 27, 2012 roberts william Officer Acquisition (Non Open Market) 11,500 n/a
Feb 11, 2014 vagelos p roy Officer Automatic Sell 11,475 325.10
May 22, 2014 van plew daniel p Officer Option Execute 11,200 21.25
Dec 16, 2010 goldberg murray a Officer Automatic Sell 11,082 31.80
Dec 16, 2010 goldberg murray a Officer Automatic Sell 11,082 31.80
Showing 361-380 of 822 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)